References
- Cohen JI, Brunell PA, Straus SE, et al. Recent advances in varicella-zoster virus infection. Ann Intern Med 1999;130:922–32
- Choo PW, Donahue JG, Manson JE, et al. The epidemiology of varicella and its complications. J Infect Dis 1995;172:706–12
- Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005;352:2266–7
- Insinga R, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005;20:748–53
- Yawn B, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341–9
- Huff JC, Bean B, Balfour HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988;85(Suppl 2A):84–8
- Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J 1989;102:93–5
- McKendrick MW, McGill JI, White JE, et al. Oral acyclovir in acute herpes zoster. Br Med J 1986;293:1529–32
- Johnson R, McElhaney J, Pedalino B, et al. Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis 2007;11:S42–S7
- Gnann J, Whitley RJ. Herpes zoster. N Engl J Med 2002;347:340–6
- Schmader K. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002;18:350–4
- Dworkin R, Schmader KE. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 2003;36:877–82
- Katz J, Cooper EM, Walther RR, et al. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004;39:342–8
- Yawn BP, Wollan PC, Kurland MJ, et al. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 2011;86:88–93
- Schmader K, Sloane R, Pieper C, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 2007;23:490–6
- Mauskopf J, Austin R, Dix L, et al. The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity. Qual Life Res 1994;3:431–5
- Oster G, Harding G, Dukes E, et al. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain 2005;6:356–63
- Lydick E, Epstein RS, Himmelberger D, et al. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology 1995;45:52–3
- Insinga R, Itzler RF, Pellissier JM. Acute/subacute herpes zoster; healthcare resource utilsation and costs in a group of US health plans. Pharmacoeconomics 2007;25:155–69
- White R, Lenhart G, Singhal PK, et al. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. PharmacoEconomics 2009;27:781–92
- Employment status of the civilian noninstitutional population by age, sex, and race. United States Bureau of Labor Statistics, 2010. Available at: http://www.bls.gov/cps/cpsaat3.pdf, accessed July 19, 2011
- Scott F, Johnson RW, Leedham-Green M, et al. The burden of herpes zoster: a prospective population based study. Vaccine 2006;24:1308–14